Allgemein Archives

SurvivX, developing a novel treatment against sepsis, was selected by INCATE Incubator community

Nijmegen, 12th September 2023 - By the occasion of the [...]

DH2023-09-12T11:55:46+02:0012. September 2023|

The next INCATE's Selection Committee is coming up and we [...]

DH2023-09-06T10:39:21+02:006. September 2023|

2023 has reached its final quarter and there are still [...]

DH2023-09-06T10:37:05+02:006. September 2023|

6th September 2023 - INCATE (the INCubator for Antibacterial Therapies [...]

DH2023-09-08T11:52:41+02:006. September 2023|

INCATE PRESS RELEASE 08, May 2023 For immediate release INCATE [...]

DH2023-05-09T11:17:26+02:008. May 2023|

All photographs - Copyright - eventfotografen.com/bamconn GmbH The AMR-Conference, Europe’s [...]

DH2023-03-27T14:42:56+02:0027. March 2023|

The INCATE Selection Committee selected another 5 ventures for Stage [...]

DH2022-12-19T13:00:10+01:0019. December 2022|

The INCATE team is expanding and we have three positions [...]

DH2023-02-13T13:38:18+01:0013. December 2022|

Who invests in Antibiotics? What are they looking for? How [...]

DH2022-09-26T11:13:47+02:0030. August 2022|

We are excited to announce our comment highlighting the INCATE [...]

DH2022-08-26T12:56:18+02:0026. August 2022|